Table 1.

The parameters at the end of the experiment of control and hypercholesterolaemic rats with or without naringin treatment.

Parameter	C	HC	HCN	CN
Initial body weight (g)	195 ± 2	196 ± 7	195 ± 10	218 ± 1
Final body weight (g)	432 ± 5	479 ± 4∗∗	428 ± 9##	424 ± 12##
Serum TC (mg/dl)	67 ± 5	346 ± 17∗∗	164 ± 14∗∗,##	67 ± 1##
Serum TG (mg/dl)	39 ± 6	82 ± 5∗∗	48 ± 5#	38 ± 2#
Serum LDL-C (mg/dl)	28 ± 7	293 ± 8∗∗	113 ± 11∗∗,##	22 ± 2##
Serum HDL-C (mg/dl)	42 ± 1	25 ± 4∗∗	43 ± 3##	37 ± 2#
AC	0.75 ± 0.32	9.62 ± 1.82∗∗∗	4.69 ± 0.57∗,##	0.81 ± 0.10###
CRR	1.75 ± 0.32	10.62 ± 1.81∗∗∗	5.69 ± 0.57∗,##	1.81 ± 0.10###
AIP	0.01 ± 0.08	0.59 ± 0.15∗∗	0.30 ± 0.06∗,#	0.02 ± 0.03##

Results are shown as mean ± SEM for 8–10 rats. ^∗p < 0.05, ^∗∗p < 0.01, and ^∗∗∗p < 0.001 vs. C group; ^#p < 0.05, ^##p < 0.01, and ^###p < 0.001 vs. HC group. TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; AC, atherogenic coefficient; CRR, cardiac risk ratio; AIP, atherogenic index of plasma.